These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 984784)

  • 1. Laboratory evaluation of BL-S786, a cephalosporin with broad-spectrum antibacterial activity.
    Leitner F; Misiek M; Pursiano TA; Buck RE; Chisholm DR; DeRegis RG; Tsai YH; Price KE
    Antimicrob Agents Chemother; 1976 Sep; 10(3):426-35. PubMed ID: 984784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BL-S786, a new parenteral cephalosporin. I. A collaborative in vitro susceptibility comparison to cephalothin against 5,762 clinical bacterial isolates.
    Jones RN; Fuchs PC; Gavan TL; Gerlach EH; Barry A; Thornsberry C
    J Antibiot (Tokyo); 1977 Jul; 30(7):576-82. PubMed ID: 893226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro activity and beta-lactamase stability of BL-S786 compared with those of other cephalosporins.
    Aswapokee N; Aswapokee P; Fu KP; Neu HC
    Antimicrob Agents Chemother; 1978 Jul; 14(1):1-5. PubMed ID: 686701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of BL-S786 with cephalothin, cefamandole and cefoxitin in vitro and in treatment of experimental infections in mice.
    Goering RV; Sanders CC; Sanders W
    J Antibiot (Tokyo); 1978 Apr; 31(4):363-72. PubMed ID: 306989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of antibacterial activities of cephalosporin antibiotics: cefazolin, cephaloridine, cephalothin, and cephalexin.
    Hsieh WC; Ho SW
    Zhonghua Min Guo Wei Sheng Wu Xue Za Zhi; 1975 Mar; 8(1):1-11. PubMed ID: 1097210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microbiological properties of a new cephalosporin, BL-S 339: 7-(phenylacetimidoyl-aminoacetamido)-3-(2-methyl-1,3,4-thiadiazol-5-ylthiomethyl)ceph-3-em-4-carboxylic acid.
    Misiek M; Pursiano TA; Leitner F; Price KE
    Antimicrob Agents Chemother; 1973 Jan; 3(1):40-8. PubMed ID: 4790575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BL-S786, a new parenteral cephalosporin. II. In vitro antimicrobial activity comparison with six related cephalosporins.
    Jones RN; Thornsberry C; Barry AL; Fuchs PC; Gavin TL; Gerlach EH
    J Antibiot (Tokyo); 1977 Jul; 30(7):583-92. PubMed ID: 893227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beta lactamase resistance of newer cephalosporins and antimicrobial effectiveness against gram-negative bacilli.
    Farrar WE; O'Dell NM
    Infection; 1977; 5(4):224-7. PubMed ID: 413793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro susceptibility of cephalothin-resistant Enterobacteriaceae to cefoxitin and BL-S786.
    Meyer RD
    J Antibiot (Tokyo); 1977 Apr; 30(4):326-9. PubMed ID: 324961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro and in vivo comparative evaluations of injectable cephalosporin derivatives and ampicillin.
    Gotô S; Kuwahara S
    Chemotherapy; 1976; 22(5):286-96. PubMed ID: 1047636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BL-S640, a cephalosporin with a broad spectrum of antibacterial activity: bioavailability and therapeutic properties in rodents.
    Leitner F; Chisholm DR; Tsai YH; Wright GE; Deregis RG; Price KE
    Antimicrob Agents Chemother; 1975 Mar; 7(3):306-10. PubMed ID: 1137382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibacterial activity of cefamandole, a new cephalosporin antibiotic, compared with that of cephaloridine, cephalothin, and cephalexin.
    Eykyn S; Jenkins C; King A; Phillips I
    Antimicrob Agents Chemother; 1973 Jun; 3(6):657-61. PubMed ID: 4790616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 7-(Alpha-(1-methyl-4-pyridinothio)-acetamido) cephalosporanic acid.
    Buck RE; Leitner F; Price KE
    Antimicrob Agents Chemother; 1972 Jan; 1(1):67-72. PubMed ID: 4670430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BL-S 640, a cephalosporin with a broad spectrum of antibacterial activity: properties in vitro.
    Leitner F; Buck RE; Misiek M; Pursiano TA; Price KE
    Antimicrob Agents Chemother; 1975 Mar; 7(3):298-305. PubMed ID: 1137381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Microbiological evaluation of cefoxitin, a new beta-lactamase resistant cephamycin antibiotic, compared to cephalothin, cephaloridine and cefazolin].
    Schassan HH; Bentfeld G
    Fortschr Med; 1978 Aug; 96(30):1510-7. PubMed ID: 669547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bactericidal activity and pharmacology of cefazolin.
    Bergeron MG; Brusch JL; Barza M; Weinstein L
    Antimicrob Agents Chemother; 1973 Oct; 4(4):396-401. PubMed ID: 4598612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cefazedone: microbiological evaluation in comparison with cephalothin and cefazolin.
    Wahlig H; Dingeldein E; Mitsuhashi S; Kawabe H
    Arzneimittelforschung; 1979; 29(2a):369-78. PubMed ID: 582712
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparison of the in vitro activity of several cephalosporin antibiotics against gram-negative and gram-positive bacteria resistant to cephaloridine.
    Kisch AL; Bartholomew L
    Antimicrob Agents Chemother; 1976 Sep; 10(3):507-10. PubMed ID: 984793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The activity of cephalosporins on beta-lactamase-producing Neisseria gonorrhoeae.
    Phillips I; Shannon K
    Scand J Infect Dis Suppl; 1978; (13):23-6. PubMed ID: 98833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new parenteral cephalosporin. SK&F 59962: in vitro and in vivo antibacterial activity and serum levels in experimental animals.
    Actor P; Uri JV; Guarini JR; Zajac I; Phillips L; Sachs CS; DeMarinis RM; Hoover JR; Weisbach JA
    J Antibiot (Tokyo); 1975 Jun; 28(6):471-6. PubMed ID: 238925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.